According to the results from Figures 4–6, Table 5 in this study, we found that CD8+RUNX1+T, CD8+RUNX2+T, CD8+RUNX3+T and CD103+CD8+RUNX3+T cells could be important prognostic predictors for the survival prediction of CRC patients. Here, RUNX2 is linked to colorectal carcinoma.